Assuring bioavailability of fixed-dose combinations of anti-tuberculosis medications. A joint statement of the International Union Against Tuberculosis and Lung Diseases and the World Health Organization.
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000592:standards; D001682:Biological Availability; D004338:Drug Combinations; D006801:Humans; D012293:Rifampin / Q000493:pharmacokinetics*; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D012293:Rifampin